USD 22.05
(-7.82%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | -68.37 Million | -193.28 Million | -95.58 Million | -66.57 Million | -44.42 Million |
Net Income | -338.69 Million | -378.67 Million | -271.1 Million | -117.57 Million | -76.56 Million |
Depreciation & Amortization | 38.91 Million | 29.72 Million | 7.9 Million | 2.83 Million | 1.85 Million |
Deferred income taxes | -361.14 Million | - | - | - | - |
Stock-based compensation | 216.87 Million | 164.46 Million | 87.88 Million | 15.91 Million | 4.34 Million |
Change in working capital | -20.15 Million | -35.36 Million | 55.63 Million | 17.67 Million | 20.22 Million |
Other non-cash items | 395.83 Million | 26.57 Million | 24.07 Million | 14.58 Million | 5.71 Million |
Investing Cash Flow | 140.59 Million | -1.31 Billion | -19.74 Million | -6.26 Million | -3.18 Million |
Investments in PPE | -18.76 Million | -18.81 Million | -10.29 Million | -6.26 Million | -2.85 Million |
Acquisitions | -13.58 Million | -281.03 Million | -3.44 Million | - | - |
Investment purchases | -466.25 Million | -1.93 Billion | -6 Million | - | -334 Thousand |
Sales/Maturities of investments | 639.19 Million | 925.18 Million | 6.64 Million | - | - |
Other Investing Activities | 155.47 Million | -1.02 Billion | -6.64 Million | -2.98 Million | -2.23 Million |
Financing Cash Flow | 47.46 Million | 36.3 Million | 1.38 Billion | 423.97 Million | 52.77 Million |
Debt repayment | - | - | -20 Million | -20 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | 19.14 Million | 19.15 Million | 11.35 Million | - | - |
Common Stock Issuance | 47.46 Million | 36.3 Million | 1.4 Billion | 424.12 Million | 52.77 Million |
Other Financing Activities | 47.46 Million | 36.3 Million | -7.41 Million | 19.85 Million | 52.77 Million |
Accounts receivables | -61.94 Million | -44.44 Million | -59.08 Million | -8.32 Million | -18.98 Million |
Accounts payables | -4.49 Million | 3.67 Million | -2.07 Million | 7.42 Million | 2.85 Million |
Inventory | - | - | - | -3.56 Million | 4.7 Million |
Other working capital | 46.29 Million | 5.4 Million | 116.79 Million | 22.13 Million | 31.65 Million |
Cash at beginning of period | 137.94 Million | 1.67 Billion | 399.11 Million | 47.68 Million | 42.48 Million |
Cash at end of period | 317.91 Million | 202.4 Million | 1.67 Billion | 399.11 Million | 47.68 Million |
Capital Expenditure | -18.76 Million | -18.81 Million | -10.29 Million | -6.26 Million | -2.85 Million |
Effect of forex changes on cash | -970 Thousand | - | 1.14 Million | 289 Thousand | 36 Thousand |
Net cash flow / Change in cash | 179.97 Million | -1.46 Billion | 1.27 Billion | 351.43 Million | 5.19 Million |
Free Cash Flow | -87.13 Million | -212.09 Million | -105.88 Million | -72.83 Million | -47.27 Million |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -338.69 Million | -71.98 Million | -70.3 Million | -89.53 Million | -106.86 Million | -378.67 Million |
Depreciation & Amortization | 38.91 Million | 10.36 Million | 9.92 Million | 9.5 Million | 9.11 Million | 29.72 Million |
Deferred income taxes | -361.14 Million | -161.51 Million | -5.9 Million | -7.92 Million | - | - |
Stock-based compensation | 216.87 Million | 53.56 Million | 54.91 Million | 52.84 Million | 55.54 Million | 164.46 Million |
Change in working capital | -20.15 Million | -13.46 Million | -24.19 Million | 10.81 Million | 6.69 Million | -35.36 Million |
Other non-cash items | 395.83 Million | 176.85 Million | 13.33 Million | 12.38 Million | 7.45 Million | 26.57 Million |
Investing Cash Flow | 140.59 Million | 113.02 Million | 12.85 Million | -16.4 Million | 31.11 Million | -1.31 Billion |
Investments in PPE | -18.76 Million | -4.52 Million | -7.36 Million | -3.32 Million | -3.54 Million | -18.81 Million |
Acquisitions | -13.58 Million | -13.58 Million | 6.74 Million | 3.29 Million | 3.08 Million | -281.03 Million |
Investment purchases | -466.25 Million | -3.71 Million | -112.12 Million | -199.77 Million | -150.63 Million | -1.93 Billion |
Sales/Maturities of investments | 639.19 Million | 134.85 Million | 132.34 Million | 186.7 Million | 185.29 Million | 925.18 Million |
Other Investing Activities | 155.47 Million | 126.8 Million | -6.74 Million | -3.29 Million | -3.08 Million | -1.02 Billion |
Financing Cash Flow | 47.46 Million | 23.68 Million | 3.52 Million | 10.49 Million | 9.76 Million | 36.3 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | 19.14 Million | 12.73 Million | - | 6.41 Million | - | 19.15 Million |
Common Stock Issuance | 47.46 Million | 23.68 Million | 3.52 Million | 10.49 Million | 9.76 Million | 36.3 Million |
Other Financing Activities | 47.46 Million | 23.68 Million | 3.52 Million | 10.49 Million | 9.76 Million | 36.3 Million |
Accounts receivables | -61.94 Million | -80.79 Million | -9.08 Million | 4.34 Million | 23.58 Million | -44.44 Million |
Accounts payables | -4.49 Million | -6.43 Million | 891 Thousand | -83 Thousand | 1.12 Million | 3.67 Million |
Inventory | - | -11.67 Million | -198 Thousand | 11.87 Million | - | - |
Other working capital | 46.29 Million | 73.76 Million | -15.8 Million | -5.31 Million | -18.01 Million | 5.4 Million |
Cash at beginning of period | 137.94 Million | 127.34 Million | 197.41 Million | 215.21 Million | 202.4 Million | 1.67 Billion |
Cash at end of period | 317.91 Million | 317.91 Million | 191.55 Million | 197.41 Million | 215.21 Million | 202.4 Million |
Capital Expenditure | -18.76 Million | -4.52 Million | -7.36 Million | -3.32 Million | -3.54 Million | -18.81 Million |
Effect of forex changes on cash | -970 Thousand | -1.21 Million | -7.79 Million | -10.89 Million | - | - |
Net cash flow / Change in cash | 179.97 Million | 190.57 Million | -5.85 Million | -17.8 Million | 12.81 Million | -1.46 Billion |
Free Cash Flow | -87.13 Million | -10.7 Million | -29.59 Million | -15.22 Million | -31.6 Million | -212.09 Million |
CKSNF
DAIUF
300787
RGXTF
CTS
9936